Abstract
Introduction. Chryseobacterium shandongense is a Gram-negative Flavobacterium bacillus with intrinsic multidrug-resistant properties. Case Presentation. Herein, we present the first case report of human C. shandongense infection, relating to an implantable portal and catheter (port-a-cath) central line in a 5-year-old female with cystic fibrosis. The infection was identified using a Bruker MALDI-TOF Biotyper with BDAL (v12) of blood, which was cultured due to pyrexia and rigour following port-a-cath access. This report details the effective eradication of C. shandongense infection from the port-a-cath device using initial empirical gentamicin followed by targeted ciprofloxacin locks and systemic antibiotics. Conclusion. We demonstrated successful eradication of C. shandongense from a port-a-cath device, including the minimum inhibitory concentrations (MICs) required in this case. The result was eradication of central access infection, preventing pro-gression to bacteraemia/septicaemia and preserving central access in a child with cystic fibrosis and established respiratory disease.
| Original language | English |
|---|---|
| Article number | 000700.v3 |
| Journal | Access Microbiology |
| Volume | 5 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chryseobacterium shandongense
- cystic fibrosis
- port-a-cath infection
Fingerprint
Dive into the research topics of 'Indwelling central venous catheter infection with Chryseobacterium shandongense – successful eradication in a 5-year-old with cystic fibrosis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver